Use of Evidence-Based Therapy for the Prevention of Cardiovascular Events Among Older people
- 27 August 2010
- journal article
- Published by SAGE Publications in Evaluation & the Health Professions
- Vol. 33 (3), 276-301
- https://doi.org/10.1177/0163278710374854
Abstract
Evidence-based therapies (EBTs) for the prevention of cardiovascular disease (CVD) are reportedly underutilized in older people. The primary purpose of this study was to evaluate the use of EBTs for the prevention of CVD events in older people and secondarily whether a Home Medicines Review (HMR) service by pharmacists’ predicts the use of these medicines. A retrospective cross-sectional audit of HMR reports pertaining to 608 community-dwelling older people (≥65 years) was conducted. EBTs considered for this audit included four guideline-recommended therapies for CVD: antithrombotic therapy (warfarin ± antiplatelet therapy), β-blockers, statins, and angiotensin agents (angiotensin-converting enzyme inhibitors [ACEI] ± angiotensin II receptor blockers [ARBs]). The prevalence of EBT use among the older people, mean age (SD) 75.6 (7.5) years, was: 73% for antithrombotic therapy, 75% for statins, 74% for angiotensin therapy, and 35% for β-blockers. CVD risk factors warranting treatment with these EBTs were frequently associated with use of EBTs. EBTs were least likely to be used in those with coronary interventions like coronary artery bypass grafting (CABG)/stent insertion (all EBTs except angiotensin agents) and angiotensin agents in those with a history of myocardial infarction or chronic heart failure. A pharmacist-led HMR service was significantly associated with the prescribing of all 4 EBTs. The results from this study show good adherence to evidence-based guidelines in general, although there is still room for improvement to further optimize clinical outcomes in these complex patients. The study also adds to the available literature on the effectiveness of pharmacists’ collaborative contribution to the care of these high-risk patients.Keywords
This publication has 47 references indexed in Scilit:
- Drug Burden Index and Potentially Inappropriate Medications in Community-Dwelling Older PeopleDrugs & Aging, 2010
- Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trialsBMJ, 2009
- Age and Persistent Use of Cardiovascular Medication After Acute Coronary Syndrome: Results from Medication Applied and Sustained Over TimeJournal of the American Geriatrics Society, 2009
- The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trialsBMJ, 2009
- Targeting Suboptimal Prescribing in the Elderly: A Review of the Impact of Pharmacy ServicesAnnals of Pharmacotherapy, 2009
- Evolution in Cardiovascular Care for Elderly Patients With Non–ST-Segment Elevation Acute Coronary SyndromesJournal of the American College of Cardiology, 2005
- Optimizing the Use of Antithrombotic Therapy for Atrial Fibrillation in Older People: A Pharmacist‐Led Multidisciplinary InterventionJournal of the American Geriatrics Society, 2005
- Gender disparities in the diagnosis and treatment of non–ST-segment elevation acute coronary syndromesJournal of the American College of Cardiology, 2005
- The impact of age on antithrombotic use in elderly patients with non-valvular atrial fibrillationAustralasian Journal on Ageing, 2002
- Adverse Outcomes and Predictors of Underuse of Antithrombotic Therapy in Medicare Beneficiaries With Chronic Atrial FibrillationStroke, 2000